T1	Chemical	31 51	adding the multidrug
T2	Gene_or_protein	31 89	adding the multidrug resistance gene-1 ( MDR-1 ) modulator
T3	Chemical	31 178	adding the multidrug resistance gene-1 ( MDR-1 ) modulator valspodar ( PSC 833 ; Novartis Pharmaceuticals , Hanover , NJ ) to chemotherapy provided
T4	Pharmacodynamic_phenotype	179 207	clinical benefit to patients
T5	Disease	223 251	acute myeloid leukemia ( AML
T6	Disease	268 298	myelodysplastic syndrome ( MDS
R1	influences	Arg1:T1	Arg2:T2
R2	influences	Arg1:T1	Arg2:T3
R3	causes	Arg1:T1	Arg2:T4
R4	treats	Arg1:T1	Arg2:T5
R5	treats	Arg1:T1	Arg2:T6
R6	influences	Arg1:T2	Arg2:T1
R7	influences	Arg1:T2	Arg2:T3
R8	treats	Arg1:T2	Arg2:T5
R9	treats	Arg1:T2	Arg2:T6
R10	influences	Arg1:T3	Arg2:T1
R11	influences	Arg1:T3	Arg2:T2
R12	causes	Arg1:T3	Arg2:T4
R13	treats	Arg1:T3	Arg2:T5
R14	treats	Arg1:T3	Arg2:T6
R15	influences	Arg1:T4	Arg2:T1
R16	influences	Arg1:T4	Arg2:T2
R17	influences	Arg1:T4	Arg2:T3
R18	treats	Arg1:T4	Arg2:T5
R19	treats	Arg1:T4	Arg2:T6
R20	influences	Arg1:T5	Arg2:T2
R21	isAssociatedWith	Arg1:T5	Arg2:T4
R22	treats	Arg1:T5	Arg2:T6
R23	isAssociatedWith	Arg1:T6	Arg2:T1
R24	isAssociatedWith	Arg1:T6	Arg2:T4
